Literature DB >> 31267684

Efficacy and tolerability of sildenafil/l-arginine combination relative to sildenafil alone in patients with organic erectile dysfunction.

L M El-Wakeel1, F A Fouad1, M D Saleem2, M Saber-Khalaf2.   

Abstract

BACKGROUND: Erectile dysfunction is defined as inability to achieve or maintain penile erection sufficient for sexual satisfaction. It is a serious problem that increases by age. The physiology of penile erection depends mainly on nitric oxide release.
OBJECTIVES: Compare the efficacy and safety of oral sildenafil 50 mg alone or in combination with l-arginine 3 g/day orally on the treatment of erectile dysfunction.
MATERIAL AND METHODS: Randomized controlled study with two parallel groups of erectile dysfunction patients; One group received sildenafil 50 mg every other day, while the other group received a combination of sildenafil (every other day)/l-arginine on a daily base. Efficacy was assessed using International Index of Erectile Function-5 score at the baseline and after 8 weeks. Side effects were evaluated across the two groups.
RESULTS: The mean age was 56.3 ± 5 and 56.2 ± 4.4 years in sildenafil and combination groups, respectively. International Index of Erectile Function-5 score was comparable between the two groups at the baseline (p value 0.44). International Index of Erectile Function-5 score was improved from 15.3 ± 2.5 at baseline to 19.2 ± 2.3 after treatment, and this was statistically significant with p value <0.0001. The score was slightly better in combination group in which the average International Index of Erectile Function-5 score was (19.8 ± 2.2) vs. (18.5 ± 2.3) in sildenafil group with p value 0.05. Side effects were more or less the same between the two groups except for gastritis which was more common on combination group.
CONCLUSION: Adding l-arginine to sildenafil demonstrated more efficacy than sildenafil alone for treatment of erectile dysfunction patients.
© 2019 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  erectile dysfunction; l-arginine; sildenafil

Mesh:

Substances:

Year:  2019        PMID: 31267684     DOI: 10.1111/andr.12671

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  6 in total

Review 1.  Alternative Treatment for Erectile Dysfunction: a Growing Arsenal in Men's Health.

Authors:  Wade Muncey; Nicholas Sellke; Tyler Kim; Kirtishri Mishra; Nannan Thirumavalavan; Aram Loeb
Journal:  Curr Urol Rep       Date:  2021-01-09       Impact factor: 3.092

2.  Canadian Urological Association guideline: Erectile dysfunction.

Authors:  Trustin Domes; Borna Tadayon Najafabadi; Matthew Roberts; Jeffrey Campbell; Ryan Flannigan; Phil Bach; Premal Patel; Gavin Langille; Yonah Krakowsky; Philippe D Violette
Journal:  Can Urol Assoc J       Date:  2021-10       Impact factor: 1.862

3.  Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis.

Authors:  Ioannis Mykoniatis; Nikolaos Pyrgidis; Ioannis Sokolakis; Andreas Ouranidis; Petros Sountoulides; Anna-Bettina Haidich; Koenraad van Renterghem; Georgios Hatzichristodoulou; Dimitrios Hatzichristou
Journal:  JAMA Netw Open       Date:  2021-02-01

4.  Adjuvant daily therapy with L-arginine 2,500 mg and tadalafil 5 mg increases efficacy and duration of benefits of low-intensity extracorporeal shock wave therapy for erectile dysfunction: A prospective, randomized, single-blinded study with 1-year follow-up.

Authors:  Luigi Gallo; Stefano Pecoraro; Pasquale Sarnacchiaro
Journal:  Investig Clin Urol       Date:  2022-01

5.  Long-term high-dose L-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial.

Authors:  D Menafra; C de Angelis; F Garifalos; M Mazzella; G Galdiero; M Piscopo; M Castoro; N Verde; C Pivonello; C Simeoli; R S Auriemma; A Colao; R Pivonello
Journal:  J Endocrinol Invest       Date:  2022-01-01       Impact factor: 4.256

Review 6.  Novel Emerging Therapies for Erectile Dysfunction.

Authors:  Soyeun Kim; Min Chul Cho; Sung Yong Cho; Hong Chung; Mahadevan Raj Rajasekaran
Journal:  World J Mens Health       Date:  2020-03-16       Impact factor: 5.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.